Lifestyle changes during the coronavirus disease 2019 pandemic impact metabolic dysfunction-associated fatty liver disease.

Hideki FujiiNaotoshi NakamuraShinya FukumotoTatsuo KimuraAkemi NakanoYuji NadataniYukie TauchiYuuko NishiiShingo TakashimaYoshihiro KamadaToshio WatanabeNorifumi Kawada

Published in: Liver international : official journal of the International Association for the Study of the Liver (2022)

New MAFLD diagnoses increased during the COVID-19 pandemic. Changes in lifestyle factors, particularly in those aged <60 years, must be monitored and addressed as the pandemic continues.

Keyphrases

coronavirus disease
metabolic syndrome
weight loss
physical activity
cardiovascular disease
respiratory syndrome coronavirus
sars cov
oxidative stress
fatty acid